Celito Tech Secures Achieve Partners Investment

Celito Tech, a tech-enabled life sciences company, has received an investment from Achieve Partners, a New York-based private equity firm. Zinnov, a global management consulting firm, served as the exclusive financial advisor to Celito Tech throughout this significant transaction.

This strategic investment marks a pivotal moment for Celito Tech, which focuses on delivering standardized platforms for biotech organizations to streamline operations and scale programs from research to commercialization. The partnership with Achieve Partners is expected to fuel Celito's continued expansion and value creation.

The transaction underscores a broader trend of increasing investor focus on specialized services platforms within the healthcare and life sciences sectors. As biotech and pharmaceutical companies advance R&D and commercialization efforts, the demand for domain-led operational partners like Celito Tech continues to rise.

Achieve Partners aims to leverage its expertise in scaling specialized platforms to support Celito's next phase of growth. This collaboration is anticipated to strengthen Achieve's presence in the biotech services landscape and bolster Celito's market reach.

Both Celito Tech and Achieve Partners expressed enthusiasm for the future, highlighting the critical role of specialized expertise in navigating the complex regulatory and technological environment of the biotech industry, especially with the advent of AI in drug development.